FDA Approves Iloperidone for Adults with Bipolar 1 Disorder
Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder.
Source: ajmc.com
Vanda Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Vanda Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Vanda Pharma Today - Breaking & Trending Today
Earnings Scheduled For February 7, 2024 - Axcelis Technologies (NASDAQ:ACLS), Advent Technologies Hldgs (NASDAQ:ADN)
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Source: benzinga.com
Stocks That Hit 52-Week Lows On Tuesday - Glimpse Group (NASDAQ:VRAR), Vor Biopharma (NASDAQ:VOR)
On Tuesday, 647 companies set new 52-week lows.
Source: benzinga.com